Micropulse laser for diabetic macular edema
Part of Cancer, Eyes & vision clinical trials.
This trial tests a gentle laser treatment called micropulse laser for diabetic macular edema, a swelling in the back of the eye caused by diabetes. It may help improve vision without the need for injections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18 years.
- You have diabetic macular edema with swelling less than 400 microns.
- Your best corrected vision is between 6/18 and 6/60 (moderate vision loss).
- You have not had previous laser, anti-VEGF injections, or vitrectomy surgery in the eye.
- You do not have extensive lack of blood flow to the retina (macular ischemia).
- You do not have other eye problems like glaucoma, scar tissue, or vein blockages.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 trial tests MS-553 to see how it works and how safely it can be given to people with diabetic retinopathy causing central macular swelling (macular edema). You may be considered if your vision and eye scan results match, and if you can follow frequent study visits.
This study compares two different eye injection treatments for diabetic macular edema (DME)—a condition where fluid builds up in the center of the retina, blurring vision. Researchers want to see how certain measures in the blood and in eye scans relate to how well each treatment works.
This study tests whether a medication called dapagliflozin, which is usually used for diabetes and heart failure, can help reduce swelling in the retina (diabetic macular edema) and improve vision. It is for people with type 2 diabetes who are already taking insulin and metformin.
This Phase 3 study compares a new eye injection (RC28-E) with the standard treatment (aflibercept) for diabetic macular edema, which is swelling in the central retina that affects vision. It aims to see whether the new treatment works as well and is safe.
This trial tests a special laser treatment for diabetic macular edema, a swelling in the back of the eye caused by diabetes. It aims to see if the laser can help patients who have not improved with standard treatment.
This study tests whether a micropulsed laser can reduce swelling in the macula (central vision area) in people with inherited retinal diseases. It may help improve or stabilize vision-related swelling seen on detailed eye scans.
Hear when a new Diabetic Macular Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.